DE60127103D1 - Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend - Google Patents

Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend

Info

Publication number
DE60127103D1
DE60127103D1 DE60127103T DE60127103T DE60127103D1 DE 60127103 D1 DE60127103 D1 DE 60127103D1 DE 60127103 T DE60127103 T DE 60127103T DE 60127103 T DE60127103 T DE 60127103T DE 60127103 D1 DE60127103 D1 DE 60127103D1
Authority
DE
Germany
Prior art keywords
norethisterone
testosterone
andecanoate
composition
male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60127103T
Other languages
English (en)
Other versions
DE60127103T2 (de
Inventor
Eberhard Nieschlag
Axel Kamischke
Michael Oettel
Alexander Ruebig
Ekkerhard Schillinger
Ursula-Friederike Habenicht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of DE60127103D1 publication Critical patent/DE60127103D1/de
Application granted granted Critical
Publication of DE60127103T2 publication Critical patent/DE60127103T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60127103T 2000-02-15 2001-02-15 Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend Expired - Lifetime DE60127103T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
US503729 2000-02-15
EP00200493 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (en) 2000-02-15 2001-02-15 Male contraceptive formulation comprising norethisterone

Publications (2)

Publication Number Publication Date
DE60127103D1 true DE60127103D1 (de) 2007-04-19
DE60127103T2 DE60127103T2 (de) 2007-11-22

Family

ID=26071832

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60127103T Expired - Lifetime DE60127103T2 (de) 2000-02-15 2001-02-15 Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend
DE60142647T Expired - Lifetime DE60142647D1 (de) 2000-02-15 2001-02-15 Zusammensetzung zur männlichen Kontrazeption, Norethisteron enthaltend

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60142647T Expired - Lifetime DE60142647D1 (de) 2000-02-15 2001-02-15 Zusammensetzung zur männlichen Kontrazeption, Norethisteron enthaltend

Country Status (26)

Country Link
EP (2) EP1666044B1 (de)
JP (1) JP2003522795A (de)
KR (1) KR20020086905A (de)
CN (1) CN1423560A (de)
AT (2) ATE355844T1 (de)
AU (1) AU2001230447A1 (de)
BG (1) BG107066A (de)
BR (1) BR0108411A (de)
CA (1) CA2398063A1 (de)
CY (1) CY1106639T1 (de)
CZ (1) CZ20022691A3 (de)
DE (2) DE60127103T2 (de)
DK (1) DK1267885T3 (de)
EE (1) EE200200454A (de)
ES (1) ES2282230T3 (de)
HK (1) HK1049442B (de)
HU (1) HUP0300128A3 (de)
IL (1) IL151219A0 (de)
MX (1) MXPA02007675A (de)
NO (1) NO20023607L (de)
PL (1) PL357185A1 (de)
PT (1) PT1267885E (de)
RU (1) RU2002124602A (de)
SI (1) SI1267885T1 (de)
SK (1) SK11602002A3 (de)
WO (1) WO2001060376A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
MXPA05001024A (es) 2002-07-24 2005-05-16 Schering Ag Metodo microbiologico para la produccion de 11 alfa-hdiroxiesteroides sustituidos en la posicion 7 alfa.
JP2006502997A (ja) * 2002-07-25 2006-01-26 シエーリング アクチエンゲゼルシャフト アンドロゲン１１β‐ハロゲンステロイドおよびゲスタゲンを含有する組成物ならびにこの組成物に基づく男性用避妊薬
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
IL277372B2 (en) 2018-03-23 2023-09-01 Laboratoires Major Non-hormonal preparations including (r)-silodosin and male contraceptive methods, including once-daily administration of (r)-silodosin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
JP2003522795A (ja) 2003-07-29
EE200200454A (et) 2003-12-15
PL357185A1 (en) 2004-07-26
AU2001230447A1 (en) 2001-08-27
ATE474580T1 (de) 2010-08-15
EP1666044B1 (de) 2010-07-21
HK1049442A1 (en) 2003-05-16
NO20023607L (no) 2002-10-15
CZ20022691A3 (cs) 2003-01-15
SK11602002A3 (sk) 2003-03-04
KR20020086905A (ko) 2002-11-20
HK1049442B (zh) 2007-06-15
PT1267885E (pt) 2007-05-31
RU2002124602A (ru) 2004-03-10
WO2001060376A1 (en) 2001-08-23
HUP0300128A3 (en) 2004-03-29
HUP0300128A2 (en) 2003-05-28
BG107066A (en) 2003-05-30
EP1666044A1 (de) 2006-06-07
IL151219A0 (en) 2003-04-10
EP1267885B1 (de) 2007-03-07
EP1267885B8 (de) 2007-06-20
SI1267885T1 (sl) 2007-08-31
ATE355844T1 (de) 2007-03-15
CY1106639T1 (el) 2012-01-25
NO20023607D0 (no) 2002-07-30
BR0108411A (pt) 2003-03-11
CA2398063A1 (en) 2001-08-23
DE60142647D1 (de) 2010-09-02
CN1423560A (zh) 2003-06-11
ES2282230T3 (es) 2007-10-16
EP1267885A1 (de) 2003-01-02
MXPA02007675A (es) 2004-02-26
DK1267885T3 (da) 2007-07-09
DE60127103T2 (de) 2007-11-22

Similar Documents

Publication Publication Date Title
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
CA2084891A1 (en) Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
JP4716726B2 (ja) 新しいエトノゲストレルエステル
DE59510887D1 (de) Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol
WO2005077968A3 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
CA2467237A1 (en) Method of preventing or treating benign gynaecological disorders
RU2001101892A (ru) Производное тестостерона
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
WO2004006936A8 (en) Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
EP1513588B1 (de) Verwendung neuer etonogestrelester
JP2003522795A5 (de)
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
IE34308B1 (en) 11beta,13beta dialkylgona-1,3,5(10)-trien-3-ol 3-cycloalkyl ethers
PL360669A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
PE20020709A1 (es) Composiciones de complejos de estrogeno-ciclodextrina
JPS5936611A (ja) 粘着性貼付製剤
CU22840A1 (es) Derivados esteroidales de la serie del androstano sustituídos en el anillo c que presentan marcada actividad anabólica e insignificante actividad androgénica
AR018349A1 (es) Composicion farmaceutica que comprende estrogenos y antiestrogenos y su uso para la manufactura de un medicamento

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE

8327 Change in the person/name/address of the patent owner

Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE

8364 No opposition during term of opposition